- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Alembic Pharma received USFDA final approval for Methotrexate Injection USP. This enables the company to market both multi-dose and single-dose vials in the US, potentially boosting future sales.